Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FURESTEM-OA Kit Inj. in Knee Osteoarthritis
NCT05944627Phase 2Not yet recruiting
- Sponsor
- Kangstem Biotech
- Start
- Jul 2023
- Primary completion
- Mar 2024
- Modality
- Mesenchymal Stem Cells
01
Overview
A Phase 2 trial of FURESTEM-OA in knee osteoarthritis (OA), sponsored by Kangstem Biotech. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
FURESTEM-OA
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05944627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944627.